BioMarin files UPC’s first pharma infringement suit in over three months
Patent owner has chosen the EU court for the opening move in what promises to be a fierce battle with rival Ascendis Pharma Register for limited access Register to receive our newsletter and gain limited access to subscriber content. Register now Subscribe …